Stock Scorecard



Stock Summary for Delcath Systems Inc (DCTH) - $13.40 as of 3/28/2025 2:48:24 PM EST

Total Score

7 out of 30

Safety Score

39 out of 100

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for DCTH

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for DCTH

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for DCTH

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for DCTH

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for DCTH (39 out of 100)

Stock Price Rating (Max of 10) 5
Historical Stock Price Rating (Max of 10) 4
Stock Price Trend (Max of 10) 9
Book Value (Max of 10) 3
Book Value to Price (Max of 10) 0
Analyst Buy Ratings (Max of 5) 4
Analyst Strong Buy Ratings (Max of 5) 4
Dividend Yield Percentage (Max of 10) 0
Operating Margin (Max of 10) 5
Trading Volume (Max of 10) 5
Price to Earnings (Max of 10) 0
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) 0

Latest News for for DCTH

Beta Bionics Announces Board Appointment of Gerard Michel - Beta Bionics ( NASDAQ:BBNX ) , Delcath Systems ( NASDAQ:DCTH ) 3/27/2025 8:45:00 PM
Beta Bionics Announces Board Appointment of Gerard Michel 3/27/2025 8:45:00 PM
Wall Street Analysts See a 58.49% Upside in Delcath Systems ( DCTH ) : Can the Stock Really Move This High? 3/26/2025 1:55:00 PM
Is aTyr Pharma ( ATYR ) Stock Outpacing Its Medical Peers This Year? 3/19/2025 1:40:00 PM
Delcath Systems, Inc. ( DCTH ) Beats Q4 Earnings and Revenue Estimates 3/6/2025 2:20:00 PM
Is Corcept Therapeutics ( CORT ) Outperforming Other Medical Stocks This Year? 2/28/2025 2:40:00 PM
Agilent Q1 Earnings Beat Estimates, Stock Falls on Cautious FY25 View 2/27/2025 4:45:00 PM
Are You Looking for a Top Momentum Pick? Why Delcath Systems, Inc. ( DCTH ) is a Great Choice 2/10/2025 5:00:00 PM
Wall Street Analysts Think Delcath Systems ( DCTH ) Could Surge 33.74%: Read This Before Placing a Bet 2/6/2025 2:55:00 PM
MicroStrategy, Portland General Electric And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Cullinan Therapeutics ( NASDAQ:CGEM ) 12/26/2024 1:49:00 PM

Financial Details for DCTH

Company Overview

Ticker DCTH
Company Name Delcath Systems Inc
Country USA
Description Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company is headquartered in New York, New York.
Sector Name LIFE SCIENCES
Industry Name SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Most Recent Quarter 12/31/2024
Next Earnings Date 5/12/2025

Stock Price History

Last Day Price 13.40
Price 4 Years Ago 7.75
Last Day Price Updated 3/28/2025 2:48:24 PM EST
Last Day Volume 412,152
Average Daily Volume 421,754
52-Week High 16.97
52-Week Low 4.26
Last Price to 52 Week Low 214.55%

Valuation Measures

Trailing PE N/A
Industry PE 64.12
Sector PE 40.10
5-Year Average PE -3.36
Free Cash Flow Ratio 31.90
Industry Free Cash Flow Ratio 29.26
Sector Free Cash Flow Ratio 47.05
Current Ratio Most Recent Quarter 1.34
Total Cash Per Share 0.42
Book Value Per Share Most Recent Quarter 2.08
Price to Book Ratio 6.51
Industry Price to Book Ratio 5.12
Sector Price to Book Ratio 21.92
Price to Sales Ratio Twelve Trailing Months 12.03
Industry Price to Sales Ratio Twelve Trailing Months 4.27
Sector Price to Sales Ratio Twelve Trailing Months 27.78
Analyst Buy Ratings 4
Analyst Strong Buy Ratings 2

Share Statistics

Total Shares Outstanding 33,403,100
Market Capitalization 447,601,540
Institutional Ownership N/A

Dividends

Ex-Dividend Date N/A
Previous Dividend Amount 0.0000
Current Dividend Amount 0.0000
Total Years Dividend Increasing N/A
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 1.97%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY 0.00%
Annual Earnings Growth -30.60%
Reported EPS 12 Trailing Months -0.93
Reported EPS Past Year -0.98
Reported EPS Prior Year -3.06
Net Income Twelve Trailing Months -34,124,000
Net Income Past Year -47,678,000
Net Income Prior Year -36,508,000
Quarterly Revenue Growth YOY 2,702.00%
5-Year Revenue Growth -9.53%
Operating Margin Twelve Trailing Months 20.10%

Balance Sheet

Total Cash Most Recent Quarter 13,992,000
Total Cash Past Year 32,454,000
Total Cash Prior Year 7,671,000
Net Cash Position Most Recent Quarter 11,992,000
Net Cash Position Past Year 22,304,000
Long Term Debt Past Year 10,150,000
Long Term Debt Prior Year 15,688,000
Total Debt Most Recent Quarter 2,000,000
Equity to Debt Ratio Past Year 0.61
Equity to Debt Ratio Most Recent Quarter 0.81
Total Stockholder Equity Past Year 15,777,000
Total Stockholder Equity Prior Year -5,859,000
Total Stockholder Equity Most Recent Quarter 8,571,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months -26,175,000
Free Cash Flow Per Share Twelve Trailing Months -0.78
Free Cash Flow Past Year -31,309,000
Free Cash Flow Prior Year -25,159,000

Options

Put/Call Ratio 3.71
Has Options Options Chain
Liquidity Rating None

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD -0.15
MACD Signal -0.27
20-Day Bollinger Lower Band 13.10
20-Day Bollinger Middle Band 13.10
20-Day Bollinger Upper Band 13.10
Beta 0.82
RSI 46.79
50-Day SMA 10.06
150-Day SMA 6.23
200-Day SMA 6.85

System

Modified 3/28/2025 10:21:55 PM EST